Literature DB >> 17498182

Overcoming opioid blockade from depot naltrexone (Prodetoxon).

E M Kruptisky1, A M Burakov, M V Tsoy, V Y Egorova, T Y Slavina, A Y Grinenko, E E Zvartau, G E Woody.   

Abstract

AIM: To describe a situation in which an opioid-dependent patient overcame naltrexone blockade. DESIGN, CASE REPORT,
SETTING: Addiction treatment center in St Petersburg, Russia. PARTICIPANT: Patient with naltrexone implant. INTERVENTION: Detoxification. MEASUREMENTS: Clinical observations.
CONCLUSIONS: It is possible, but very difficult, to overcome naltrexone blockade by using large doses of heroin.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17498182     DOI： 10.1111/j.1360-0443.2007.01817.x

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


  9 in total

Review 1.  Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available.

Authors:  Evgeny Krupitsky; Edwin Zvartau; George Woody
Journal:  Curr Psychiatry Rep       Date:  2010-10       Impact factor: 5.285

2.  Pharmacologically assisted treatment of opioid-dependent youth.

Authors:  Anna Pecoraro; Marc Fishman; Michelle Ma; Gvantsa Piralishvili; George E Woody
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

Review 3.  Antagonist Models for Relapse Prevention and Reducing HIV Risk.

Authors:  George E Woody; Evgeny Krupitsky; Edwin Zvartau
Journal:  J Neuroimmune Pharmacol       Date:  2016-02-27       Impact factor: 4.147

Review 4.  The globalization of addiction research: capacity-building mechanisms and selected examples.

Authors:  Richard A Rawson; George Woody; Thomas F Kresina; Steven Gust
Journal:  Harv Rev Psychiatry       Date:  2015 Mar-Apr       Impact factor: 3.732

5.  Factors associated with using opiates while under extended-release naltrexone blockade: A descriptive pilot study.

Authors:  Brantley P Jarvis; Anthony DeFulio; Lauren Long; August F Holtyn; Annie Umbricht; Michael Fingerhood; George E Bigelow; Kenneth Silverman
Journal:  J Subst Abuse Treat       Date:  2016-12-24

Review 6.  Potential uses of naltrexone in emergency department patients with opioid use disorder.

Authors:  Evan Stuart Bradley; David Liss; Stephanie Pepper Carreiro; David Eric Brush; Kavita Babu
Journal:  Clin Toxicol (Phila)       Date:  2019-03-04       Impact factor: 4.467

7.  Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence.

Authors:  Evgeny Krupitsky; Edwin Zvartau; Elena Blokhina; Elena Verbitskaya; Valentina Wahlgren; Marina Tsoy-Podosenin; Natalia Bushara; Andrey Burakov; Dmitry Masalov; Tatyana Romanova; Arina Tyurina; Vladimir Palatkin; Tatyana Slavina; Anna Pecoraro; George E Woody
Journal:  Arch Gen Psychiatry       Date:  2012-09

Review 8.  Injectable and implantable sustained release naltrexone in the treatment of opioid addiction.

Authors:  Nikolaj Kunøe; Philipp Lobmaier; Hanh Ngo; Gary Hulse
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

9.  Long-acting Preparations in Substance Abuse Management: A Review and Update.

Authors:  Aditya Hegde; Shubh Mohan Singh; Siddharth Sarkar
Journal:  Indian J Psychol Med       Date:  2013-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.